Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
125 hedge funds and large institutions have $281M invested in Sucampo Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 6 closing their positions.
567% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 6
63% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 30
55% more capital invested
Capital invested by funds: $182M → $281M (+$99.2M)
37% more funds holding
Funds holding: 91 → 125 (+34)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less call options, than puts
Call options by funds: $658K | Put options by funds: $792K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$10.2M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.98M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$6.98M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$5.76M |
| 5 |
AIC
AWM Investment Company
New York
|
+$4.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$6.32M |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$2.69M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.67M |
| 4 |
Millennium Management
New York
|
-$2.11M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.4M |
SCMP Hedge Fund Activity: Q1 2015 in Review
125 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q1 2015, worth a combined $281M — up 55% from $182M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new SCMP positions and 6 closed out — a net gain of 34 holders — while 49 added to existing stakes and 30 trimmed.
The largest buyer was Granahan Investment Management, adding an estimated $10.2M. The largest seller was Putnam Investments, cutting an estimated $6.32M.
- 125 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q1 2015, up from 91 in Q4 2014.
- Funds reported $281M of Sucampo Pharmaceuticals, Inc. stock for Q1 2015, up 55% quarter-over-quarter.
- 40 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q1 2015 and 6 closed out, a net change of +34 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q1 2015 was Granahan Investment Management, an estimated $10.2M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q1 2015 was Putnam Investments, an estimated $6.32M sold.
Based on aggregated 13F filings for Q1 2015.